Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
The Pharmacological Basis of Therapeutics
1976 • 8,675 citations
The Pharmacological Basis of Therapeutics
1976 • 1,283 citations
THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES
1958 • 634 citations
Inhibition of tumour growth in vivo and in vitro by prostaglandin E
1976 • 196 citations
The relationship between concentration of prostaglandin E and rates of cell replication
1974 • 133 citations
Effect of Vincristine on the Fine Structure of HeLa Cells During Mitosis<xref ref-type="fn" rid="FN2">2</xref>
1965 • 133 citations
Immunodeficiency And Cancer
1973 • 110 citations
Dopamine: A Novel Antitumor Agent Active Against B-16 Melanoma In Vivo
1978 • 92 citations
Influence of PGE on the immune response in melanoma-bearing mice.
1980 • 69 citations
Inhibition of DNA synthesis in harding-passey melanoma cells by prostaglandins A1 and A2: Comparison with chemotherapeutic agents
1979 • 53 citations
Inhibition of B-16 melanoma growth in vivo by a synthetic analog of prostaglandin E2.
1977 • 50 citations
The effect of PGA1 on the immune response in B-16 melanoma-bearing mice
1980 • 31 citations
Prostaglandin E (PGE) control of cell proliferation in vitro: Characteristics of HT-29
1974 • 29 citations
Dose dependent inhibition of B-16 melanoma growth in vivo by a synthetic analogue of PGE2
1977 • 27 citations